Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
The real time saving in vaccine development is not in the preclinical development itself, but in the accelerated clinical development and reduced regulatory process of dossier preparation and review.
Although less than 12% of current research funding in the life sciences derives from industry, we are witnessing the growth of a multimillion dollar academic-industrial alliance, a venture that brings significant benefit—and misgivings.
Understanding the intimate connection between activation and desensitization in seven-membrane-spanning receptors may lead to new therapies for heart disease